G. Drelichman, “Eliglustat, a new substrate reduction therapy for adult patients with Gaucher disease type 1: effectiveness at 6 years evaluated in three centers of Argentine”, RH, vol. 23, no. 3, pp. 25–34, Dec. 2019.